Comprehensive Genomic Analysis in Tissue Samples From Patients With Recurrent or Stage IV Non-small Cell Lung Cancer
Public ClinicalTrials.gov record NCT02178163. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Study to Assess the Ability to Initiate Therapy in Advanced Non-small Cell Lung Cancer (NSCLC) Patients Based on Genomic Analyses of Tumor Specimens.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This research trial studies comprehensive genomic analysis in tissue samples from patients with non-small cell lung cancer that has come back or is stage IV. Comprehensive genomic analysis may identify specific gene mutations (changes in deoxyribonucleic acid \[DNA\]) and help doctors to tailor treatment to target the specific mutations.
Study identification
- NCT ID
- NCT02178163
- Recruitment status
- Active, not recruiting
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 619 participants
Conditions and interventions
Interventions
Other
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 1, 2014 (Actual)
- Primary completion
- Jul 2027 (Estimated)
- Completion
- Jul 2027 (Estimated)
- Last update posted
- Jul 29, 2026
2014 – 2027
United States locations
- U.S. sites
- 11
- U.S. states
- 1
- U.S. cities
- 11
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| KCI at McLaren Bay Region | Bay City | Michigan | 48708 | — |
| KCI at Mclaren Bloomfield Hills | Bloomfield Hills | Michigan | 48302 | — |
| KCI At McLaren Clarkston | Clarkston | Michigan | 48346 | — |
| Barbara Ann Karmanos Cancer Institute | Detroit | Michigan | 48201 | — |
| KCI at McLaren Flint | Flint | Michigan | 48532 | — |
| KCI at McLaren Greater Lansing, Mid Michigan Physicians | Lansing | Michigan | 48910 | — |
| KCI at McLaren Lapeer Region | Lapeer | Michigan | 48446 | — |
| KCI at McLaren Macomb | Mount Clemens | Michigan | 48043 | — |
| KCI at McLaren Central Michigan | Mount Pleasant | Michigan | 48858 | — |
| KCI at Northern Michigan | Petoskey | Michigan | 49770 | — |
| KCI at McLaren Port Huron | Port Huron | Michigan | 48060 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02178163, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 29, 2026 · Synced Oct 26, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02178163 live on ClinicalTrials.gov.